Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2020 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Appoints Paul G. Thomas to Board of Directors

Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of Directors ALACHUA, Fla., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in...
September 25, 2020 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit

ALACHUA, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
September 24, 2020 07:00 ET | Source: Axogen, Inc.

Axogen to Participate in the 75th Annual American Society for Surgery of the Hand Meeting

ALACHUA, Fla., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
August 31, 2020 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference

ALACHUA, Fla., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
August 05, 2020 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Reports Second Quarter 2020 Financial Results

ALACHUA, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
July 29, 2020 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

ALACHUA, Fla., July 29, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
July 22, 2020 07:00 ET | Source: Axogen, Inc.

Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects

ALACHUA, Fla., July 22, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
July 15, 2020 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020

ALACHUA, Fla., July 15, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
July 01, 2020 07:00 ET | Source: Axogen, Inc.

Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate

ALACHUA, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced...
June 01, 2020 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer

ALACHUA, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...

keyboard_arrow_left Previous Page